ID
36768
Description
Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria This study (Malaria-039 / NCT00323622 / GlaxoSmithKline Study ID 104297) is a two-year follow-up to Malaria-026 and consists of three clinic visits: Visit 1 / Informed Consent Visit at Visit 7 of Malaria-026 (i.e. 21 months post vaccine dose 1 in Malaria-026). Visit 2 / Interim Analysis 12 months +/- 1 month after Visit 1. Visit 3 / Final Analysis 24 months +/- 1 month after Visit 1. See https://clinicaltrials.gov/ct2/show/NCT00323622 This form is to be completed at Visit 2.
Lien
https://clinicaltrials.gov/ct2/show/NCT00323622
Mots-clés
Versions (2)
- 11/12/2018 11/12/2018 -
- 06/06/2019 06/06/2019 -
Détendeur de droits
GSK group of companies
Téléchargé le
6 juin 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Immunogenicity of malaria vaccine candidate - NCT00323622 / Malaria-039
Visit 2: Study Continuation Check
- StudyEvent: ODM
Description
Check for Study Continuation
Alias
- UMLS CUI-1
- C2348568
- UMLS CUI-2
- C0805733
Description
If Yes, please complete the next pages. If No, Please tick the ONE most appropriate reason and skip the following pages of this visit, and please tick who took the decision.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C0805733
- UMLS CUI [1,3]
- C0008976
Description
Reason for discontinuation
Type de données
text
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [1,3]
- C0008976
Description
complete the Serious Adverse Event form
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0600091
- UMLS CUI [1,2]
- C1519255
Description
e.g.: consent withdrawal, Protocol violation, non-serious adverse event …
Type de données
text
Alias
- UMLS CUI [1,1]
- C3840932
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [1,3]
- C0008976
- UMLS CUI [1,4]
- C1521902
Description
Discontinuation decision
Type de données
text
Alias
- UMLS CUI [1,1]
- C0679006
- UMLS CUI [1,2]
- C0457454
- UMLS CUI [1,3]
- C0008976
Similar models
Visit 2: Study Continuation Check
- StudyEvent: ODM
C0805733 (UMLS CUI-2)
C0805733 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0457454 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1519255 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
C0457454 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])